Cyclacel Pharmaceuticals Reports Third Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. PINS
4. COIN
5. RDDT
6. FSLR
7. SYK
8. SBUX
9. SNDK
10. MA

Go back to Cyclacel Pharmaceuticals Reports Third Quarter 2020 Financial Results

Cyclacel Pharma (CYCC) Tops Q3 EPS by 8c

November 11, 2020 4:36 PM EST

Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.47), $0.08 better than the analyst estimate of ($0.55).

We continue to execute on our clinical development plan for fadraciclib and CYC140 in both liquid and solid cancers, said Spiro Rombotis, President and Chief Executive Officer. The recent ENA presentation... More